Adolfo Perez-Bonet
Adolfo Perez-Bonet has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Aman Goyal
Department of General Surgery, Mahatma Gandhi Medical College and Research Institute, Pondicherry, Cuddalore Rd, ECR, Pillayarkuppam, Puducherry 607402, India
8 shared publications - Rodolfo J. Oviedo
University of Houston Tilman J. Fertitta Family College of Medicine, Houston, TX, USA; Sam Houston State University College of Osteopathic Medicine, Conroe, TX, USA; Bariatric Surgical Services, Department of Surgery, Nacogdoches Medical Center, Nacogdoches, TX, USA; Robotics Program, Departament of Surgery, Nacogdoches Medical Center, Nacogdoches, TX, USA
8 shared publications - Christian Adrian Macias
Health Science Department Hillsborough College 33614 Tampa FL USA
6 shared publications - Abhirami Babu
College of Medicine, Our Lady of Fatima University, Valenzuela, Philippines
4 shared publications - Adel Abou-Mrad
Department of Surgery, Centre Hospitalier Universitaire d’Orléans, 45000 Orléans, France
4 shared publications - Luigi Marano
Department of Surgery, Dnipro State Medical University, Dnipro, Ukraine
4 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by IntechOpen
Advanced Endobariatric Therapies for the Management of Bariatric Surgery Complications
Metabolic and bariatric surgery (MBS) remains the most effective treatment for severe obesity and metabolic comorbidities, offering durable weight loss and superior outcomes compared with non-surgical approaches. However, despite operative refinements, enhanced recovery pathways, and perioperative optimization, complications can arise early or years postoperatively. These range from anastomotic leaks, intraluminal bleeding, strictures, marginal ulcers, perforations, and fistulas to functional disorders such as dumping syndrome and recurrent weight gain (RWG). Managing these challenges requires prompt diagnosis, multidisciplinary evaluation, and a stepwise, individualized treatment strategy. Endobariatric therapy has emerged as a vital component of bariatric care, serving both as a primary metabolic intervention and as an effective rescue platform. Modern therapeutic endoscopic techniques, including tissue apposition systems, pneumatic dilation, septotomy, stricture disruption, fully covered self-expanding metal stents (SEMS), over-the-scope clips (OTSC), endoscopic internal drainage (EID), transoral outlet reduction (TORe), endoscopic sleeve revision, and endoluminal remodeling, provide high precision, safety, and durability, often preserving altered anatomy while averting morbid revisional surgery. This chapter reviews current evidence, rescue maneuvers, and clinical protocols for managing post-MBS complications, emphasizing treatment sequencing, candidate selection, and decision-making in high-risk patients. Furthermore, it highlights the expanding role of artificial intelligence (AI), robotic-assisted endoscopy, standardized staging pathways, and predictive modeling in enhancing procedural planning, durability, and safety. As these innovations advance, endobariatrics is transitioning from an adjunct modality to a fundamental pillar of comprehensive bariatric practice, redefining modern standards of care.
- 22 October 2026
- Published by IntechOpen
Open AccessAdvanced Endobariatric Therapies for the Management of Bariatric Surgery Complications
Metabolic and bariatric surgery (MBS) remains the most effective treatment for severe obesity and metabolic comorbidities, offering durable weight loss and superior outcomes compared with non-surgical approaches. However, despite operative refinements, enhanced recovery pathways, and perioperative optimization, complications can arise early or years postoperatively. These range from anastomotic leaks, intraluminal bleeding, strictures, marginal ulcers, perforations, and fistulas to functional disorders such as dumping syndrome and recurrent weight gain (RWG). Managing these challenges requires prompt diagnosis, multidisciplinary evaluation, and a stepwise, individualized treatment strategy. Endobariatric therapy has emerged as a vital component of bariatric care, serving both as a primary metabolic intervention and as an effective rescue platform. Modern therapeutic endoscopic techniques, including tissue apposition systems, pneumatic dilation, septotomy, stricture disruption, fully covered self-expanding metal stents (SEMS), over-the-scope clips (OTSC), endoscopic internal drainage (EID), transoral outlet reduction (TORe), endoscopic sleeve revision, and endoluminal remodeling, provide high precision, safety, and durability, often preserving altered anatomy while averting morbid revisional surgery. This chapter reviews current evidence, rescue maneuvers, and clinical protocols for managing post-MBS complications, emphasizing treatment sequencing, candidate selection, and decision-making in high-risk patients. Furthermore, it highlights the expanding role of artificial intelligence (AI), robotic-assisted endoscopy, standardized staging pathways, and predictive modeling in enhancing procedural planning, durability, and safety. As these innovations advance, endobariatrics is transitioning from an adjunct modality to a fundamental pillar of comprehensive bariatric practice, redefining modern standards of care.
- Open Access
- 9 October 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (4) , 59
Gut Microbiome Alterations, Microbial Metabolites and Hepatobiliary Cancer: A Descriptive Systematic Review of the Microbial–Metabolic Axis
Background: Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are considered major causes of cancer-related mortality. Evidence suggests that gut microbiome dysbiosis and the microbial–metabolic axis and its metabolites in hepatic chronic inflammation might be implicated in carcinogenesis in the gut–liver axis. This descriptive systematic review examines the microbial–metabolic axis in hepatobiliary cancer, focusing on patterns of dysbiosis, microbiome-associated metabolites, and the diagnostic or prognostic potential in this field. Methods: This manuscript was developed according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420261455009). PubMed, Scopus, Cochrane Library, Web of Science, and Embase were searched. Eligible studies were published medical manuscripts reporting gut (oral/duodenal/fecal) microbiome alterations with links to HCC or CCA. Risk of bias was assessed with Rob 2.0 for the randomized clinical trial study included in this manuscript and ROBINS-I for the non-randomized studies. Ultimately, 13 studies met the inclusion criteria and were included in this qualitative study. Results: In the included studies, patients with HCC or CCA showed altered gut microbial diversity, a depletion of beneficial taxa such as Faecalibacterium and Bifidobacterium, and increased levels of potentially pro-inflammatory genera. Specific signatures such as Alloprevotella and the B.F.R. genera models in CCA were associated with diagnostic performance, with AUCs that frequently exceeded 0.90 in internal validation. Furthermore, circulating and host microbial metabolites, such as methionine, methionine sulfoxide, taurocholic acid, and microbial-derived TMA/TMAO pathway components, were associated with HCC risk. Conclusions: According to our analysis, gut microbiome alterations are associated with HCC and CCA and show promising diagnostic and prognostic potential. The findings are consistent with a possible microbial–metabolic contribution to hepatocarcinogenesis through chronic inflammatory and metabolic pathways. However, most included studies evaluated virus-related liver disease, and direct evidence linking obesity or MASLD-related dysbiosis to hepatobiliary cancer remains limited. Prospective and interventional investigations of metabolic liver disease populations are needed to clarify this axis.
- 9 October 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (4) , 59
Open AccessGut Microbiome Alterations, Microbial Metabolites and Hepatobiliary Cancer: A Descriptive Systematic Review of the Microbial–Metabolic Axis
Background: Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are considered major causes of cancer-related mortality. Evidence suggests that gut microbiome dysbiosis and the microbial–metabolic axis and its metabolites in hepatic chronic inflammation might be implicated in carcinogenesis in the gut–liver axis. This descriptive systematic review examines the microbial–metabolic axis in hepatobiliary cancer, focusing on patterns of dysbiosis, microbiome-associated metabolites, and the diagnostic or prognostic potential in this field. Methods: This manuscript was developed according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420261455009). PubMed, Scopus, Cochrane Library, Web of Science, and Embase were searched. Eligible studies were published medical manuscripts reporting gut (oral/duodenal/fecal) microbiome alterations with links to HCC or CCA. Risk of bias was assessed with Rob 2.0 for the randomized clinical trial study included in this manuscript and ROBINS-I for the non-randomized studies. Ultimately, 13 studies met the inclusion criteria and were included in this qualitative study. Results: In the included studies, patients with HCC or CCA showed altered gut microbial diversity, a depletion of beneficial taxa such as Faecalibacterium and Bifidobacterium, and increased levels of potentially pro-inflammatory genera. Specific signatures such as Alloprevotella and the B.F.R. genera models in CCA were associated with diagnostic performance, with AUCs that frequently exceeded 0.90 in internal validation. Furthermore, circulating and host microbial metabolites, such as methionine, methionine sulfoxide, taurocholic acid, and microbial-derived TMA/TMAO pathway components, were associated with HCC risk. Conclusions: According to our analysis, gut microbiome alterations are associated with HCC and CCA and show promising diagnostic and prognostic potential. The findings are consistent with a possible microbial–metabolic contribution to hepatocarcinogenesis through chronic inflammatory and metabolic pathways. However, most included studies evaluated virus-related liver disease, and direct evidence linking obesity or MASLD-related dysbiosis to hepatobiliary cancer remains limited. Prospective and interventional investigations of metabolic liver disease populations are needed to clarify this axis.
- Open Access
- 25 September 2026
- Published by IntechOpen
AI in Endo-Bariatrics
Artificial intelligence (AI) is increasingly influencing the field of endo-bariatrics by bringing greater precision, personalization, and efficiency to the management of obesity and metabolic diseases. This chapter examines how AI can be integrated across endoscopic bariatric and metabolic therapies (EBMTs from patient selection, to pre-procedure planning, intra-op support, and long-term follow-up. Traditionally, EBMT outcomes have often depended on the operator’s experience, which can lead to variability in results and a lack of standardized practice. AI technologies such as machine learning, deep learning, computer vision, and predictive analytics can help overcome these limitations by enabling more data-driven decisions, automatic recognition of anatomical structures, and real-time procedural support. In the pre-procedure stage, AI can assist with advanced imaging analysis, volumetric assessment, and simulation models that help clinicians plan individualized treatment strategies. During procedures, AI-assisted visualization systems, robotic support, depth sensing, and predictive tools for complications may improve procedural safety and consistency. Post-procedure, AI-enabled mobile applications and wearable device can allow continuous monitoring of patients, provide behavioral guidance, and help detect complications at an early stage, and improve long-term outcomes. Aditionally, AI may also improve workflow efficiency, reduce costs, standardize training, and help expand access to EBMTs. However, wider use of AI in endo-bariatrics faces several challenges such as concerns about data bias, lack of transparency, medico-legal responsibility, and unequal global access. Therefore, careful evaluation of AI systems is essential for safe implementation. AI has the potential to shift endo-bariatrics from a largely technique-dependent field to a more predictive, data-driven, and precision-based discipline.
- 25 September 2026
- Published by IntechOpen
Open AccessAI in Endo-Bariatrics
Artificial intelligence (AI) is increasingly influencing the field of endo-bariatrics by bringing greater precision, personalization, and efficiency to the management of obesity and metabolic diseases. This chapter examines how AI can be integrated across endoscopic bariatric and metabolic therapies (EBMTs from patient selection, to pre-procedure planning, intra-op support, and long-term follow-up. Traditionally, EBMT outcomes have often depended on the operator’s experience, which can lead to variability in results and a lack of standardized practice. AI technologies such as machine learning, deep learning, computer vision, and predictive analytics can help overcome these limitations by enabling more data-driven decisions, automatic recognition of anatomical structures, and real-time procedural support. In the pre-procedure stage, AI can assist with advanced imaging analysis, volumetric assessment, and simulation models that help clinicians plan individualized treatment strategies. During procedures, AI-assisted visualization systems, robotic support, depth sensing, and predictive tools for complications may improve procedural safety and consistency. Post-procedure, AI-enabled mobile applications and wearable device can allow continuous monitoring of patients, provide behavioral guidance, and help detect complications at an early stage, and improve long-term outcomes. Aditionally, AI may also improve workflow efficiency, reduce costs, standardize training, and help expand access to EBMTs. However, wider use of AI in endo-bariatrics faces several challenges such as concerns about data bias, lack of transparency, medico-legal responsibility, and unequal global access. Therefore, careful evaluation of AI systems is essential for safe implementation. AI has the potential to shift endo-bariatrics from a largely technique-dependent field to a more predictive, data-driven, and precision-based discipline.
- Open Access
The LO-VEg Project—A School-Based Nudging and Communication Intervention to Promote Vegetable and Legume Consumption: Preliminary Evidence from an Ecological Study in Italian Primary Schools
Background/Objectives: In Italy, food waste within school meal services represents a major public health and sustainability challenge, with approximately 21.7% of meals discarded, and vegetables and legumes among the most frequently rejected components. Low consumption of these foods during childhood contributes to unhealthy dietary trajectories and increased long-term cardiometabolic risk. Evidence indicates that information-based nutrition education alone is insufficient to modify children’s eating behaviors within complex food environments. This study aimed to describe and evaluate the LO-VEg project, a school-based intervention designed to address dietary behavior and food waste simultaneously by integrating environmental nudging with child-centered communication strategies. Methods: The LO-VEg project was implemented as a quasi-experimental ecological school-based intervention combining environmental nudging strategies and multisensory communication tools to promote vegetable and legume consumption in primary school canteens. The intervention involved approximately 1500 pupils across four primary schools in the Lombardy region of Italy and was conducted over a 10-week period within routine school meal settings. Consumption outcomes were assessed through aggregated anonymous plate-waste observations collected during school meals. Results: Preliminary aggregated analyses indicated favorable trends in vegetable and legume consumption and plate-waste reduction during the intervention period. The broader intervention architecture also included communication, digital, and family-oriented components, which are described in the present manuscript as part of the implementation framework. Conclusions: The LO-VEg project suggests that integrating environmental nudging with child-centered communication strategies may represent a scalable approach to improving dietary behaviors and reducing food waste in school settings.
Open AccessThe LO-VEg Project—A School-Based Nudging and Communication Intervention to Promote Vegetable and Legume Consumption: Preliminary Evidence from an Ecological Study in Italian Primary Schools
Background/Objectives: In Italy, food waste within school meal services represents a major public health and sustainability challenge, with approximately 21.7% of meals discarded, and vegetables and legumes among the most frequently rejected components. Low consumption of these foods during childhood contributes to unhealthy dietary trajectories and increased long-term cardiometabolic risk. Evidence indicates that information-based nutrition education alone is insufficient to modify children’s eating behaviors within complex food environments. This study aimed to describe and evaluate the LO-VEg project, a school-based intervention designed to address dietary behavior and food waste simultaneously by integrating environmental nudging with child-centered communication strategies. Methods: The LO-VEg project was implemented as a quasi-experimental ecological school-based intervention combining environmental nudging strategies and multisensory communication tools to promote vegetable and legume consumption in primary school canteens. The intervention involved approximately 1500 pupils across four primary schools in the Lombardy region of Italy and was conducted over a 10-week period within routine school meal settings. Consumption outcomes were assessed through aggregated anonymous plate-waste observations collected during school meals. Results: Preliminary aggregated analyses indicated favorable trends in vegetable and legume consumption and plate-waste reduction during the intervention period. The broader intervention architecture also included communication, digital, and family-oriented components, which are described in the present manuscript as part of the implementation framework. Conclusions: The LO-VEg project suggests that integrating environmental nudging with child-centered communication strategies may represent a scalable approach to improving dietary behaviors and reducing food waste in school settings.
- Top Cited PapersOpen Access
- 13 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2208
Artificial Intelligence Applications in Gastric Cancer Surgery: Bridging Early Diagnosis and Responsible Precision Medicine
Background: Artificial intelligence is emerging as a promising tool in surgical oncology, with growing evidence suggesting potential applications in diagnostic support, intraoperative guidance, and perioperative risk assessment. In gastric cancer surgery, emerging applications range from AI-assisted endoscopic detection to data-driven perioperative risk prediction, while some technological developments, particularly in robotic autonomy, derive from broader surgical or experimental models that may inform future gastric procedures. Methods: A narrative review was conducted following established methodological standards, including the Scale for the Assessment of Narrative Review Articles (SANRA) and the Search–Appraisal–Synthesis–Analysis (SALSA) framework. English-language studies indexed in PubMed, Scopus, Embase, and Web of Science up to October 2025 were included. Evidence was synthesized thematically across five domains: AI-assisted anatomical recognition and lymphadenectomy support, autonomous robotic systems, early cancer detection, perioperative predictive and frailty models, and ethical and regulatory considerations. Results: AI-based computer vision and deep learning algorithms have demonstrated promising capabilities for real-time anatomical recognition, surgical phase classification, and intraoperative guidance, although evidence of direct patient-level benefit remains limited. In diagnostic settings, AI-assisted endoscopy and Raman spectroscopy have been shown to improve early lesion detection and reduce dependence on operator experience. Predictive models, including MySurgeryRisk and AI-driven frailty assessments, may support individualized prehabilitation planning and perioperative risk stratification. Persistent limitations include small and heterogeneous datasets, insufficient external validation, and unresolved concerns related to data privacy, algorithmic interpretability, and medico-legal responsibility. Conclusions: Artificial intelligence is progressively emerging as a promising tool in gastric cancer surgery, integrating automation, advanced analytics, and human clinical reasoning. Its safe and ethical adoption requires robust validation, transparent governance, and continuous surgeon oversight. When developed within human-centered and ethically grounded frameworks, AI can augment, rather than replace, surgical expertise, potentially advancing precision, safety, and equity in oncologic care.
- 13 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2208
Top Cited PapersOpen AccessArtificial Intelligence Applications in Gastric Cancer Surgery: Bridging Early Diagnosis and Responsible Precision Medicine
Background: Artificial intelligence is emerging as a promising tool in surgical oncology, with growing evidence suggesting potential applications in diagnostic support, intraoperative guidance, and perioperative risk assessment. In gastric cancer surgery, emerging applications range from AI-assisted endoscopic detection to data-driven perioperative risk prediction, while some technological developments, particularly in robotic autonomy, derive from broader surgical or experimental models that may inform future gastric procedures. Methods: A narrative review was conducted following established methodological standards, including the Scale for the Assessment of Narrative Review Articles (SANRA) and the Search–Appraisal–Synthesis–Analysis (SALSA) framework. English-language studies indexed in PubMed, Scopus, Embase, and Web of Science up to October 2025 were included. Evidence was synthesized thematically across five domains: AI-assisted anatomical recognition and lymphadenectomy support, autonomous robotic systems, early cancer detection, perioperative predictive and frailty models, and ethical and regulatory considerations. Results: AI-based computer vision and deep learning algorithms have demonstrated promising capabilities for real-time anatomical recognition, surgical phase classification, and intraoperative guidance, although evidence of direct patient-level benefit remains limited. In diagnostic settings, AI-assisted endoscopy and Raman spectroscopy have been shown to improve early lesion detection and reduce dependence on operator experience. Predictive models, including MySurgeryRisk and AI-driven frailty assessments, may support individualized prehabilitation planning and perioperative risk stratification. Persistent limitations include small and heterogeneous datasets, insufficient external validation, and unresolved concerns related to data privacy, algorithmic interpretability, and medico-legal responsibility. Conclusions: Artificial intelligence is progressively emerging as a promising tool in gastric cancer surgery, integrating automation, advanced analytics, and human clinical reasoning. Its safe and ethical adoption requires robust validation, transparent governance, and continuous surgeon oversight. When developed within human-centered and ethically grounded frameworks, AI can augment, rather than replace, surgical expertise, potentially advancing precision, safety, and equity in oncologic care.
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Intelligent Surgery
- Vol. 9, 87-108
The surgeon in the loop: Artificial intelligence, robotic surgery, and the future of surgical judgment, performance, and training
- 1 January 2026
- Published by KEAI Publishing in Intelligent Surgery
- Vol. 9, 87-108
Open AccessThe surgeon in the loop: Artificial intelligence, robotic surgery, and the future of surgical judgment, performance, and training
- 22 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 35
SETY©: A next-generation robotic training platform for safe and autonomous surgery in space — surgical biomechatronics design and Hardware-Software integration within the SY-MIS project
Introduction Surgical capability in space is constrained by extreme conditions such as microgravity, communication latency, surgical training, and limited resources. Current robotic training platforms are optimized for terrestrial use. The objective is to explore The SETY© platform, developed under the SY-MIS program, designed as a compact and accessible mechatronic surgical platform for minimally invasive procedures with emphasis on operational feasibility in resource-limited and early robotic training exposure to prepare future surgeons for extreme and spaceflight conditions. The final goal is to overcome some barriers for surgeons in their initial phases of training such as earlier exposure to a robotic platform, limited training lab availability, portability issues, on demand practice, affordability of robotic platform, and improving overall surgical proficiency and patient care. Design, setting, and participants This experimental feasibility study (2022–2024) involved the SETY© system in terrestrial analog environments simulating microgravity constraints. The system incorporated ergonomic considerations, low-cost components, and an open-source control architecture to enhance accessibility for academic and clinical training. The platform consisted of dual articulated robotic arms mounted on a compact 400 × 500 mm base, driven by servomechanism motors via a curved rail mechanism. Structural components were produced using 3D-printed PLA and validated via finite element analysis. The electrical system employed an ESP32 microcontroller for console input and an Arduino Nano for arm control, enabling real-time coordination of eight servomotors through potentiometer and joystick inputs. Primary platform outcomes were mechanical stability, kinematic precision (velocity and torque control), synchronization between console and arms, and robustness under repetitive cycles. Secondary platforms outcomes included compactness, energy efficiency, and feasibility for integration into training curricula. Results Finite element analysis confirmed a maximum Von Mises stress of 0.482 MPa and minimal deformation (0.0007 mm), yielding a safety factor of 15. The system maintained joint velocities below 10°/s and torques under 10 N·m. Simulation with sinusoidal inputs showed stable motion patterns, velocity peaks at ± 4°/s, torque oscillations around ± 0.05 N·m, and acceleration up to 1500°/s². Electrical integration achieved smooth real-time synchronization without predictive filtering, although the absence of ROS-based frameworks reduced interoperability and limited integration with higher-level control systems. Minor mechanical tolerances and sensor variance were observed but did not compromise functionality. Conclusions The SETY© platform demonstrated mechanical robustness, precise motion control, and functional reliability within a compact, energy-efficient design. Its low-cost, open-source configuration supports adoption in surgical and medical engineering education and has potential applicability for space mission surgical preparedness. Future refinements should optimize mechanical damping and material stiffness to enhance performance under high-load or rapid-maneuver conditions.
- 22 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 35
SETY©: A next-generation robotic training platform for safe and autonomous surgery in space — surgical biomechatronics design and Hardware-Software integration within the SY-MIS project
Introduction Surgical capability in space is constrained by extreme conditions such as microgravity, communication latency, surgical training, and limited resources. Current robotic training platforms are optimized for terrestrial use. The objective is to explore The SETY© platform, developed under the SY-MIS program, designed as a compact and accessible mechatronic surgical platform for minimally invasive procedures with emphasis on operational feasibility in resource-limited and early robotic training exposure to prepare future surgeons for extreme and spaceflight conditions. The final goal is to overcome some barriers for surgeons in their initial phases of training such as earlier exposure to a robotic platform, limited training lab availability, portability issues, on demand practice, affordability of robotic platform, and improving overall surgical proficiency and patient care. Design, setting, and participants This experimental feasibility study (2022–2024) involved the SETY© system in terrestrial analog environments simulating microgravity constraints. The system incorporated ergonomic considerations, low-cost components, and an open-source control architecture to enhance accessibility for academic and clinical training. The platform consisted of dual articulated robotic arms mounted on a compact 400 × 500 mm base, driven by servomechanism motors via a curved rail mechanism. Structural components were produced using 3D-printed PLA and validated via finite element analysis. The electrical system employed an ESP32 microcontroller for console input and an Arduino Nano for arm control, enabling real-time coordination of eight servomotors through potentiometer and joystick inputs. Primary platform outcomes were mechanical stability, kinematic precision (velocity and torque control), synchronization between console and arms, and robustness under repetitive cycles. Secondary platforms outcomes included compactness, energy efficiency, and feasibility for integration into training curricula. Results Finite element analysis confirmed a maximum Von Mises stress of 0.482 MPa and minimal deformation (0.0007 mm), yielding a safety factor of 15. The system maintained joint velocities below 10°/s and torques under 10 N·m. Simulation with sinusoidal inputs showed stable motion patterns, velocity peaks at ± 4°/s, torque oscillations around ± 0.05 N·m, and acceleration up to 1500°/s². Electrical integration achieved smooth real-time synchronization without predictive filtering, although the absence of ROS-based frameworks reduced interoperability and limited integration with higher-level control systems. Minor mechanical tolerances and sensor variance were observed but did not compromise functionality. Conclusions The SETY© platform demonstrated mechanical robustness, precise motion control, and functional reliability within a compact, energy-efficient design. Its low-cost, open-source configuration supports adoption in surgical and medical engineering education and has potential applicability for space mission surgical preparedness. Future refinements should optimize mechanical damping and material stiffness to enhance performance under high-load or rapid-maneuver conditions.
- Top Cited PapersOpen Access
Perioperative Immunonutrition in Gastrointestinal Oncology: A Comprehensive Umbrella Review and Meta-Analysis on Behalf of TROGSS—The Robotic Global Surgical Society
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery. Methods: A systematic search of PubMed, Scopus, and the Cochrane Library was conducted on 28 October 2024 in accordance with PRISMA guidelines. Systematic reviews and meta-analyses evaluating perioperative IMN versus standard care in adult patients undergoing GI cancer surgery were included in the search. The outcomes assessed included infectious and non-infectious complications, wound healing, hospital stay, and nutritional status. The study quality was evaluated using AMSTAR 2, and the meta-analysis was conducted using random-effects models to calculate the pooled effect sizes (risk ratios [RRs], odds ratios [ORs], mean differences [MDs]) with 95% confidence intervals (CIs). Results: Sixteen systematic reviews and meta-analyses, including a total of 41,072 patients, were included. IMN significantly reduced infectious complications (RR: 0.62, 95% CI: 0.55–0.70; I2 = 63.0%), including urinary tract infections (RR: 0.74, 95% CI: 0.61–0.89; I2 = 0.0%) and wound infections (OR: 0.64, 95% CI: 0.55–0.73; I2 = 34.4%). Anastomotic leak rates were notably lower (RR: 0.68, 95% CI: 0.62–0.75; I2 = 8.2%). While no significant reduction in pneumonia risk was observed, non-infectious complications decreased significantly (RR: 0.83, 95% CI: 0.75–0.92; I2 = 30.6%). IMN also reduced the length of hospital stay by an average of 1.92 days (MD: −1.92, 95% CI: −2.36 to −1.48; I2 = 73.5%). Conclusions: IMN provides significant benefits in GI cancer surgery, reducing complications and improving recovery. However, variability in protocols and populations highlight the need for standardization and further high-quality trials to optimize its application and to validate its efficacy in enhancing surgical care.
Top Cited PapersOpen AccessPerioperative Immunonutrition in Gastrointestinal Oncology: A Comprehensive Umbrella Review and Meta-Analysis on Behalf of TROGSS—The Robotic Global Surgical Society
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery. Methods: A systematic search of PubMed, Scopus, and the Cochrane Library was conducted on 28 October 2024 in accordance with PRISMA guidelines. Systematic reviews and meta-analyses evaluating perioperative IMN versus standard care in adult patients undergoing GI cancer surgery were included in the search. The outcomes assessed included infectious and non-infectious complications, wound healing, hospital stay, and nutritional status. The study quality was evaluated using AMSTAR 2, and the meta-analysis was conducted using random-effects models to calculate the pooled effect sizes (risk ratios [RRs], odds ratios [ORs], mean differences [MDs]) with 95% confidence intervals (CIs). Results: Sixteen systematic reviews and meta-analyses, including a total of 41,072 patients, were included. IMN significantly reduced infectious complications (RR: 0.62, 95% CI: 0.55–0.70; I2 = 63.0%), including urinary tract infections (RR: 0.74, 95% CI: 0.61–0.89; I2 = 0.0%) and wound infections (OR: 0.64, 95% CI: 0.55–0.73; I2 = 34.4%). Anastomotic leak rates were notably lower (RR: 0.68, 95% CI: 0.62–0.75; I2 = 8.2%). While no significant reduction in pneumonia risk was observed, non-infectious complications decreased significantly (RR: 0.83, 95% CI: 0.75–0.92; I2 = 30.6%). IMN also reduced the length of hospital stay by an average of 1.92 days (MD: −1.92, 95% CI: −2.36 to −1.48; I2 = 73.5%). Conclusions: IMN provides significant benefits in GI cancer surgery, reducing complications and improving recovery. However, variability in protocols and populations highlight the need for standardization and further high-quality trials to optimize its application and to validate its efficacy in enhancing surgical care.